CSPC PHARMA News

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024

Nov 1 17:30

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS FURTHER CLINICAL TRIAL APPROVAL FOR NEW INDICATION

Oct 25 18:45

CSPC PHARMA: NEXT DAY DISCLOSURE RETURN

Oct 15 16:50

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - OMALIZUMAB FOR INJECTION OBTAINS MARKETING APPROVAL GRANTED BY NMPA

Oct 8 16:57

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - CPO301 RECEIVES FAST TRACK DESIGNATION FROM THE US FDA

Oct 8 16:55

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT FOR YS2302018 WITH ASTRAZENECA

Oct 7 16:31

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024

Oct 2 16:38

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF JSKN003 IN MAINLAND CHINA

Sep 30 06:02

CSPC PHARMA: NEXT DAY DISCLOSURE RETURN

Sep 20 17:14

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - VALSARTAN LEVOAMLODIPINE MALEATE TABLETS OBTAINS CLINICAL TRIAL APPROVAL

Sep 20 16:52

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - FURTHER SHARE BUY-BACK PLAN OF UP TO HK$5 BILLION

Sep 19 18:28

CSPC PHARMA: NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM

Sep 19 18:02

CSPC PHARMA: NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM

Sep 19 18:01

CSPC PHARMA: LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM

Sep 19 18:01

CSPC PHARMA: NEXT DAY DISCLOSURE RETURNS

Sep 17 16:50

CSPC PHARMA: NEXT DAY DISCLOSURE RETURNS

Sep 16 16:50

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - AMPHOTERICIN B LIPOSOME FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

Sep 16 12:01

CSPC PHARMA: NEXT DAY DISCLOSURE RETURNS

Sep 13 17:02

CSPC PHARMA: NEXT DAY DISCLOSURE RETURNS

Sep 12 17:12

CSPC PHARMA: NEXT DAY DISCLOSURE RETURNS

Sep 11 17:09